GlassScriptPhysician profile
Frank Michael Alea
NPI 1932153525
$725.88
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $72.35 · 2021: $85.08 · 2022: $17.26 · 2023: $137 · 2024: $77.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $149.96 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.43 | 2019-2024 | |
| Novo Nordisk INC | $131.09 | 2019-2020 | |
| Smith+Nephew, INC. | $70.52 | 2021-2023 | Renasys Go V2 Home, Pico |
| Convatec INC. | $47.17 | 2023 | |
| Sanofi-Aventis U.S. LLC | $33.09 | 2019 | |
| Reprise Biomedical, INC. | $22.76 | 2024 | Miro3d |
| Kerecis Limited | $21.93 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Glaxosmithkline, LLC. | $17.26 | 2022 | |
| Mimedx Group, INC. | $17.25 | 2024 | |
| Next Science LLC | $16.43 | 2023 | Xperience, Blastx, Surgx |
| Corcept Therapeutics | $15.77 | 2021 | |
| Ovik Health, LLC | $15.53 | 2024 | Coflex Tlc |
| Medtronic Vascular, INC. | $14.56 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Alea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.